Clinical Trial Update: An Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group [NA]

View source ↗

Summary

A clinical trial evaluating the performance and safety of pHyPh for vulvovaginal candidiasis in adult women, compared with no treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• pHyph

Snippet

Sponsor: Gedea Biotech AB | Conditions: Vulvovaginal Candidiasis (VVC) | NA | Status: RECRUITING